ReviewAlcoholism, clinical and experimental research2015
Commonalities and Differences Across Substance Use Disorders: Phenomenological and Epidemiological Aspects.
Review in Alcoholism, clinical and experimental research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 62 citations in OpenAlex.
- Cannabis use and beliefs among people in recovery from substance use disorders.Journal of cannabis research · 2026Article
- Brief Addiction Monitor-Taiwan version as a simple tool for the measurement-based care of people who use drugs in the era of harm reduction: predictive validity in prospective follow-ups of patients nationwide.Substance abuse treatment, prevention, and policy · 2026Article
- A digital cognitive behavioral therapy program culturally adapted for Spanish-speaking individuals with alcohol use disorder: a stage 1 randomized clinical trial.Frontiers in digital health · 2026Article
- The epidemiology of substance use disorders in Saudi Arabia: findings from the Saudi national mental health survey.BMC public health · 2025Article
- Network analysis of Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) 3.1 items for non-medical use of alcohol, tobacco, cannabis, prescription sedatives, prescription stimulants, and prescription opioids.Frontiers in psychiatry · 2025Article
- Association patterns of antisocial personality disorder across substance use disorders.Translational psychiatry · 2024Article
- Reply on "Why compulsive sexual behavior is not a form of addiction like drug addiction".Sexual medicine · 2024Article
- Assessing sugar-sweetened beverage consumption in early pregnancy using a substance abuse framework.Scientific reports · 2023Article
- Test characteristics of shorter versions of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) for brief screening for problematic substance use in a population sample from Israel.Substance abuse treatment, prevention, and policy · 2023Article
- Can severity of substance use be measured across drug classes? Estimating differential item functioning by drug class in two general measures of substance use severity.Drug and alcohol dependence · 2023Article
- Examining neurobehavioral differences that support success in recovery from alcohol and other substance use disorders.Journal of substance use and addiction treatment · 2023Observational
- Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use.Journal of psychiatric research · 2022Article
- Reappraising Choice in Addiction: Novel Conceptualizations and Treatments for Tobacco Use Disorder.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022Article
- Associations of cannabis- and tobacco-related problem severity with reward and punishment sensitivity and impulsivity in adolescent daily cigarette smokers.International journal of mental health and addiction · 2021Article
- Network-Based Discovery of Opioid Use Vulnerability in Rats Using the Bayesian Stochastic Block Model.Frontiers in psychiatry · 2021Article
- Metabolomics in Psychiatric Disorders: What We Learn from Animal Models.Metabolites · 2020Review
- Risk factors for alcohol use among pregnant women, ages 15-44, in the United States, 2002 to 2017.Preventive medicine · 2019Article
- An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use.European archives of psychiatry and clinical neuroscience · 2019Review
- Trends in cannabis use disorder by cigarette smoking status in the United States, 2002-2016.Drug and alcohol dependence · 2018Article
- Associations Between Divorce and Onset of Drug Abuse in a Swedish National Sample.American journal of epidemiology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundAlthough psychoactive substances vary in many ways, they have important commonalties, particularly in their ability to lead to an addiction syndrome. The field lacks an updated review of the commonalities and differences in the phenomenology of alcohol, cannabis, tobacco, stimulants, opioids, hallucinogens, sedatives/tranquilizers, and inhalants and their related substance use disorders (SUDs).
methodsDSM-IV and DSM-5 SUD diagnostic criteria were reviewed, as was evidence from recent epidemiological and clinical research: psychometric studies (test-retest reliability, latent trait analysis); physiological indicators (tolerance, withdrawal); prevalence and age of onset. Information was incorporated from previous reviews, PubMed and Scopus literature searches, and data from large U.S. national surveys.
resultsEmpirical evidence in the form of test-retest reliability and unidimensionality supports use of the same DSM-IV dependence or DSM-5 SUD diagnostic criteria across substances. For most substances, the criteria sets were generally most informative in general population samples at moderate-to-severe levels of SUD. Across substances, 2 criteria (tolerance and use in hazardous situations) were identified as functioning differently in population subgroups. Since substances have different pharmacological effects, withdrawal is assessed using substance-specific symptoms, while tolerance is not; issues remain with the assessment of tolerance. Alcohol, tobacco, and cannabis were consistently identified as the substances with earliest onset of use, highest prevalence of lifetime use, and highest prevalence of lifetime disorder.
conclusionsDespite differences between psychoactive substances, the generic DSM criteria set appears equally applicable across substances. Additional studies of tolerance and hazardous use will be useful for future nosologies. Alcohol, cannabis, and tobacco are the substances with the greatest public health impact due to the high prevalence and early onset of their use, and the potential all 3 substances have to lead to addiction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.